News

Tariffs threaten generic drug production and supply - Fmr. FDA commissioner
Proposed tariffs on pharmaceutical imports could destabilize U.S. generic drug supply, warns Dr. Scott Gottlieb.
Dr. Scott Gottlieb: RFK Jr. has been very focused on dismantling the U.S. vaccine enterprise
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the resignation of top FDA vaccine official Dr. Peter Marks, impact on vaccine development and approvals, HHS Secretary Kennedy ...
Tariffs on generic drugs will cause companies to stop making them: Former FDA Commissioner Gottlieb
Dr. Scott Gottlieb, former FDA Commissioner, joins 'Squawk Box' to discuss current pharmaceutical imports under investigation, moving production for branded and generic drugs elsewhere, and much more.
Yahoo Finance22d
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Scott Gottlieb, MD, has been elected non-executive Chair of Illumina's Board. Dr. Gottlieb has served on the Board of Directors since 2020. Additionally, Keith Meister, founder, Managing Partner ...
MM&M14d
Former FDA Commissioner Scott Gottlieb weighs in on RFK Jr., HHS cuts
Dr. Scott Gottlieb, the former FDA Commissioner under President Donald Trump from 2017 to 2019, discussed the impact of recent layoffs at HHS and how it could adversely impact the industry at the 2025 ...
J&J Plans $400 Million in Extra Tariff Costs Even Before Trump’s Drug Tariffs Begin
The price of pharmaceuticals will likely go up soon, and generics are poised to be hit the hardest.
Hosted on MSN25d
Dr. Scott Gottlieb says RFK Jr.'s suggested alternatives to the MMR vaccine are "not viable"
Dr. Scott Gottlieb, the former FDA commissioner, tells "Face the Nation with Margaret Brennan" that Health and Human Services Secretary Robert F. Kennedy Jr.'s suggested alternatives to the MMR ...